The most frequent PPOs included the lack of laxatives in patients with chronic constipation and/or receiving opioids, the lack of sodium-glucose cotransporter-2 (SGLT-2) inhibitors and mineralocorticoid receptor antagonist (MRA) in heart failure, and the lack of statins in patients with a history of cardiovascular disease. This evidence concerns the gene NR3C2 and cardiovascular disorder.